3/17
11:03 am
bcrx
BioCryst: The Buyout Rumor Is Noise, The Franchise Is Real [Seeking Alpha]
Low
Report
BioCryst: The Buyout Rumor Is Noise, The Franchise Is Real [Seeking Alpha]
3/17
12:55 am
bcrx
BioCryst (BCRX) Soars 13% on Acquisition Buzz [Yahoo! Finance]
Low
Report
BioCryst (BCRX) Soars 13% on Acquisition Buzz [Yahoo! Finance]
3/10
08:10 am
bcrx
BioCryst Pharma (BCRX) Subject to Prise Target Raise by Wedbush [Yahoo! Finance]
Low
Report
BioCryst Pharma (BCRX) Subject to Prise Target Raise by Wedbush [Yahoo! Finance]
3/6
06:09 am
bcrx
BioCryst Pharmaceuticals (BCRX) was upgraded by
Weiss Ratings from "sell (d-)" to "hold (c)".
Low
Report
BioCryst Pharmaceuticals (BCRX) was upgraded by
Weiss Ratings from "sell (d-)" to "hold (c)".
3/4
07:25 am
bcrx
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Low
Report
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
3/4
07:00 am
bcrx
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/2
04:43 am
bcrx
A Look At BioCryst Pharmaceuticals (BCRX) Valuation As Net Income Turns Positive And Astria Deal Expands HAE Portfolio [Yahoo! Finance]
Low
Report
A Look At BioCryst Pharmaceuticals (BCRX) Valuation As Net Income Turns Positive And Astria Deal Expands HAE Portfolio [Yahoo! Finance]
3/1
07:02 pm
bcrx
BioCryst's First Profitable Year Recasts Hereditary Angioedema Growth Story [Yahoo! Finance]
Low
Report
BioCryst's First Profitable Year Recasts Hereditary Angioedema Growth Story [Yahoo! Finance]
2/28
07:38 am
bcrx
BioCryst (BCRX) Soars 10.8% on Swing to Profits [Yahoo! Finance]
Low
Report
BioCryst (BCRX) Soars 10.8% on Swing to Profits [Yahoo! Finance]
2/27
12:00 am
bcrx
Where is BioCryst Pharmaceuticals (BCRX) Headed According to the Street? [Yahoo! Finance]
High
Report
Where is BioCryst Pharmaceuticals (BCRX) Headed According to the Street? [Yahoo! Finance]
2/26
04:42 pm
bcrx
BioCryst Pharmaceuticals Inc (BCRX) Q4 2025 Earnings Call Highlights: Record Profitability and ... [Yahoo! Finance]
High
Report
BioCryst Pharmaceuticals Inc (BCRX) Q4 2025 Earnings Call Highlights: Record Profitability and ... [Yahoo! Finance]
2/26
07:32 am
bcrx
BioCryst Reports Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
BioCryst Reports Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
2/26
07:00 am
bcrx
BioCryst Reports Full Year 2025 Financial Results and Provides Business Update
Low
Report
BioCryst Reports Full Year 2025 Financial Results and Provides Business Update
2/25
01:39 pm
bcrx
Are BioCryst Pharmaceuticals (BCRX) Shares Offering Value After Recent Price Rebound [Yahoo! Finance]
Low
Report
Are BioCryst Pharmaceuticals (BCRX) Shares Offering Value After Recent Price Rebound [Yahoo! Finance]
2/18
08:43 am
bcrx
BioCryst Pharmaceuticals (NASDAQ:BCRX) is now covered by analysts at Evercore Inc. They set an "outperform" rating and a $17.00 price target on the stock.
Medium
Report
BioCryst Pharmaceuticals (NASDAQ:BCRX) is now covered by analysts at Evercore Inc. They set an "outperform" rating and a $17.00 price target on the stock.
2/17
07:00 am
bcrx
BioCryst to Present at Upcoming Investor Conference
Low
Report
BioCryst to Present at Upcoming Investor Conference
2/11
07:00 am
bcrx
BioCryst to Present New HAE Data from ORLADEYO® (berotralstat) and Navenibart at the 2026 American Academy of Allergy, Asthma & Immunology Annual Meeting
Medium
Report
BioCryst to Present New HAE Data from ORLADEYO® (berotralstat) and Navenibart at the 2026 American Academy of Allergy, Asthma & Immunology Annual Meeting
2/7
01:03 am
bcrx
Jim Cramer on BioCryst Pharmaceuticals: “Just Stay Away From That” [Yahoo! Finance]
Low
Report
Jim Cramer on BioCryst Pharmaceuticals: “Just Stay Away From That” [Yahoo! Finance]
2/5
07:01 am
bcrx
BioCryst to Report Fourth Quarter 2025 Financial Results on February 26
Medium
Report
BioCryst to Report Fourth Quarter 2025 Financial Results on February 26
2/5
07:00 am
bcrx
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1/30
10:38 am
bcrx
BioCryst Pharmaceuticals (NASDAQ:BCRX) had its price target lowered by analysts at Royal Bank Of Canada from $14.00 to $13.00. They now have an "outperform" rating on the stock.
Low
Report
BioCryst Pharmaceuticals (NASDAQ:BCRX) had its price target lowered by analysts at Royal Bank Of Canada from $14.00 to $13.00. They now have an "outperform" rating on the stock.
1/24
04:36 pm
bcrx
Assessing BioCryst Pharmaceuticals (BCRX) Valuation After Recent Share Price Pressure And Rare Disease Pipeline Focus [Yahoo! Finance]
Low
Report
Assessing BioCryst Pharmaceuticals (BCRX) Valuation After Recent Share Price Pressure And Rare Disease Pipeline Focus [Yahoo! Finance]
1/23
09:00 am
bcrx
BioCryst Completes Acquisition of Astria Therapeutics, Expanding Leadership in Hereditary Angioedema
Low
Report
BioCryst Completes Acquisition of Astria Therapeutics, Expanding Leadership in Hereditary Angioedema
1/22
02:36 pm
bcrx
BioCryst: The $700 Million Pivot From Oral Convenience To Injectable [Seeking Alpha]
Low
Report
BioCryst: The $700 Million Pivot From Oral Convenience To Injectable [Seeking Alpha]
1/21
04:22 pm
bcrx
Astria Stockholders Vote to Approve Acquisition by BioCryst [Yahoo! Finance]
Low
Report
Astria Stockholders Vote to Approve Acquisition by BioCryst [Yahoo! Finance]